Don't miss

Replay


LATEST SHOWS

DEBATE

Greece Takes on Europe: Historic Elections Rock Status Quo (part 2)

Read more

DEBATE

Greece Takes on Europe: Historic Elections Rock Status Quo (part 1)

Read more

MEDIAWATCH

Far-left and far-right celebrate Syriza's victory

Read more

THE INTERVIEW

Colombia's Santos hoping for end to FARC conflict 'this year'

Read more

TALKING EUROPE

Fighting terrorism: Does Europe have a plan?

Read more

ENCORE!

Music show: Björk, Charlie Winston and Ray Lema

Read more

FOCUS

Eastern Ukraine dragged deeper into war

Read more

TALKING EUROPE

What would a Syriza victory mean for Greece?

Read more

FOCUS

Set, the new pro-Putin youth movement

Read more

Americas

Obama earmarks $1.8 billion for fight against pandemic

Text by NEWS WIRES

Latest update : 2009-07-16

US President Barack Obama has designated more than $1.8 billion in emergency funds to fight a pandemic of influenza A(H1N1), or swine flu. The money will mainly go toward producing vaccines and helping plan immunisation campaigns.

REUTERS - President Barack Obama designated $1.825 billion on Thursday for emergency use to fight the new pandemic of H1N1 swine flu.

 

The money will go to buy vaccine ingredients, to help health officials plan immunization campaigns and to help get the vaccines approved at the U.S. Food and Drug Administration, Obama said in a letter to House of Representatives Speaker Nancy Pelosi.

 

"To enhance our nation's capability to respond to the potential spread of this outbreak, and in accordance with the appropriation, I hereby designate $1.825 billion of the contingent appropriation as emergency funds required to address critical needs related to emerging influenza viruses (specifically, the virus known as 2009-H1N1)," Obama wrote.

 

The money comes from $7.65 billion Congress already appropriated to the Department of Health and Human Services for the swine flu pandemic.

 

The World Health Organization said earlier on Thursday that the H1N1 flu pandemic was the fastest-moving ever and that it was now pointless to count every case.

 

WHO said at least 50 governments have placed orders for vaccines and WHO vaccine chief Marie-Paule Kieny told Reuters the potential global value of the market was estimated at between $10 billion and $20 billion.

 

 Sanofi-Aventis, Novartis, Baxter, GlaxoSmithKline, and AstraZeneca's MedImmune unit all have H1N1 vaccines for the U.S. market.

 

Date created : 2009-07-16

COMMENT(S)